Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

 

Recent News and Articles on the Keywords: epilepsy + 0.26 + child  Related to the article below (Last Update: 8/5/2008)

Psychopathological factors, memory disorders and transient global ...
British Journal of Psychiatry (subscription), UK - Jul 31, 2008
There was no group effect on the intensity scores for the 18- to 30-year-old (F(2,57)=1.04, P=0.36) and the past 10-year periods (F(2,57)=1.36, P =0.26). ...
Source: Google News

ADHD and epilepsy in childhood -
DW Dunn, JK Austin, J Harezlak - Developmental Medicine & Child Neurology, 2003 - Blackwell Synergy
... Epilepsy syndrome Generalized/idiopathic 52 29.7 ... with all CBCL scales and subscales
(r>0.26). Children with generalized tonic?clonic seizures had a ...

Additional educational needs in children born to mothers with epilepsy -
N Adab, A Jacoby, D Smith, D Chadwick - British Medical Journal, 2001 - jnnp.bmj.com
... by contrast with an odds ratio of 0.26 (95% CI ... particular risks for the development
of children exposed in ... 2001;70:15-21) Keywords: epilepsy; pregnancy outcomes ...

Status epilepticus in children with newly diagnosed epilepsy -
AT Berg, S Shinnar, SR Levy, FM Testa - Annals of Neurology, 1999 - doi.wiley.com
... normal scans or incidental findings (p 0.26). SE was more common in children with
partial sei- zures (12%) and localization-related epilepsy (11%) compared ...

Validation of a New Quality of Life Measure for Children with Epilepsy -
M Sabaz, DR Cairns, JA Lawson, N Nheu, AF Bleasel, … - Epilepsia, 2000 - Blackwell Synergy
... E-mail: a.bye@unsw.edu.au HRQOL of children with epilepsy are the Child Health
Questionnaire (CHQ) (1 1,14) and the Child Behaviour Checklist (CBCL) (9,15). ...

Carbamazepine and its 10, 11-epoxide in children and adults with epilepsy -
S Pynn?nen, M Sillanp??, H Frey, E Iisalo - European Journal of Clinical Pharmacology, 1977 - Springer
... years) and 13 adults (age 16-57, mean 36.9 years) with various types of epilepsy. ...
difference was the higher ratio of CBZ-E to CBZ in children (0.26) than in ...

Long-Term Treatment of Children with Epilepsy with Valproate or Carbamazepine May Cause Subclinical … -
J Eiris-Punal, MD Rio-Garma, MC Rio-Garma, S Lojo- … - Epilepsia, 1999 - Blackwell Synergy
... The 141 subjects with epilepsy were divided into three groups ... 0.27 1.42 f: 0.21 1.54
k 0.23' 1.67 2 0.26 ... The latter two patients were a child with infantile ab ...

Symptoms of Depression in Adolescents With Epilepsy. -
DW DUNN, JK AUSTIN, GA HUSTER - … of the American Academy of Child & Adolescent Psychiatry, 1999 - jaacap.com
... child variables (attitudes toward epilepsy, satisfaction with ... Mother Stigma 0.28
.0030 0.26 .0046 Note ... Children's Depression Inventory; YSR = Youth Self- 14.47 ...

… Drug-Related Cognitive Complaints in Seizure-Free Children with Epilepsy Before and After Drug … -
AP Aldenkamp, WCJ Alpherts, P Sandstedt, G Blennow … - Epilepsia, 1998 - Blackwell Synergy
... the children, second coeficient is for the parents. Values > 0.26 are significant
During treatment After discontinuation Cognitive domain Duration of epilepsy ...

… Life Inventory TM (PedsQL TM) in childhood cancer patients off treatment and children with epilepsy -
R Felder-Puig, E Frey, K Proksch, JW Varni, H … - Quality of Life Research, 2004 - Springer
... epilepsy group, the only major difference was seen in emotional functioning, where
the correlation be- tween children?s and parents? responses was 0.26. ...

Informant Agreement in Behavior Ratings for Children with Epilepsy -
TJ Huberty, JK Austin, J Harezlak, DW Dunn, WT … - Epilepsy and Behavior, 2000 - Elsevier
... by gender and by active versus inactive epilepsy status. ... Social Problems 0.28 0.26
0.002 0.99 0.63 0.25 ... that it would be difficult to classify a child as being ...

Source: Google Scholar

Largest Childhood Epilepsy Study Worldwide Reveals Common Concerns Among Children, Parents And Healthcare Professionals
27th International Epilepsy Congress, Singapore -Survey[i] data presented by Eric Hargis, Secretary General, International Bureau for Epilepsy (IBE) shed light on the common concerns and fears of children living with epilepsy, their carers and healthcare professionals. Nine out of 10 (94%) healthcare professionals said that advice on reducing seizures is the most frequent information request from parents and children, followed by information on cognitive (79%) and physical (75%) side effects of antiepileptic drugs. Furthermore, parents are concerned about the ability of their child to keep up with school work (35%); learn new things (27%) and participate in sports / other hobbies (27%).
"Achieving seizure freedom with minimum side effects must be the primary goal for the management of epilepsy in children and adolescents to provide the best possible potential for neurological, cognitive and psychosocial development and educational outcomes. " said Professor Alexis Arzimanoglou, Head of the Epilepsy Program, University Hospital Robert Debré, Paris, France. He continued, "This survey, conducted across 16 countries, highlights that a stigma still surrounds epilepsy, with up to a third of children and almost a quarter of parents/carers reluctant to inform people about their condition for fear of being treated differently."

As part of their ongoing work to increase understanding and awareness of epilepsy, UCB today announces the launch of Live Beyond Epilepsy, an international initiative designed to enhance the lives of people with epilepsy, those who live with them and those who care for them.

Launched today to support Live Beyond Epilepsy, 'BE Inspired: The Inspiring Experiences of People Living with Epilepsy' is a booklet that captures the hopes, challenges and dreams of people with the condition through artwork and prose. By sharing the personal messages and experiences of people with epilepsy, support and encouragement can be provided to other people living with the condition.

"UCB Pharma is committed to enhancing the lives of people with epilepsy, their families and carers, and through this new initiative - Live Beyond Epilepsy - is working to create greater awareness and understanding of the condition." said Dr. Kenneth Saké, Associate Director, Global Medical Affairs, UCB Pharma.

Today, there are around 50 million people with epilepsy in the world, making it one of the most common neurological disorders.[ii] Every year there are 2.4 million new cases globally and at least 50 percent of new cases begin in childhood or adolescence. ii

The Future in Mind survey is the largest of its kind in children with epilepsy, involving over 1,000 responses from children and teenagers with epilepsy, carers and healthcare professionals from 16 different countries.i
About Future in Mind Survey

'Future in Mind' is an educational initiative by the International Bureau for Epilepsy (IBE) to raise awareness of the considerations and consequences of childhood epilepsy. The IBE survey of children and teenagers with epilepsy was designed to assess the perceptions of people directly involved with childhood epilepsy. This is the first time that the views of children and teenagers with epilepsy, parents, caregivers and healthcare professionals from around the world have been gathered as part of a single survey on epilepsy. This report presents findings of the survey, including over 1,000 responses from children and teenagers with epilepsy, parents, caregivers and healthcare professionals from 16 different countries. 'Future in Mind' is supported by UCB.

About the International Bureau for Epilepsy

The IBE, with 113 member associations based in 88 countries worldwide, exists to improve the social condition and quality of life of people with epilepsy and those who care for them. IBE has a vision of the world where everywhere ignorance and fear about epilepsy are replaced by understanding and care. Find out more by contacting ibedublin@eircom.net or by visiting the website http://www.ibe-epilepsy.org

About Live Beyond Epilepsy

Live Beyond Epilepsy is an epilepsy awareness and education initiative from UCB. It brings together a series of innovative programmes designed to improve the lives of people with epilepsy, those who live with them and those who care for them.

The artistic work in 'Be Inspired: The Inspiring Experiences of People Living with Epilepsy' was drawn together from entries to the 'Freedom in Mind' (http://www.freedominmind.com) initiative. Freedom in Mind is a joint initiative of UCB and the International Bureau for Epilepsy. This initiative calls upon people with epilepsy to express what freedom from seizures means to them, through pictures, poems, readings, music and films.

About UCB Pharma SA

Headquartered in Brussels (Belgium), UCB (http://www.ucb-group.com) is a leading global biopharmaceutical company dedicated to the research, development and commercialisation of innovative pharmaceutical and biotechnology products in the fields of central nervous system disorders, allergy/respiratory diseases, immune and inflammatory disorders and oncology - UCB focuses on securing a leading position in severe disease categories. Employing more than 8400 people in over 40 countries, UCB achieved revenue of 2.5 billion euro in 2006. UCB is listed on the Euronext Brussels Exchange and owns 87.6% of Schwarz Pharma.

References

[i] Hargis E., Baker G., Arzimanoglou A., Glauser T., Pellock J., Hsih M.S., Mounfield H. and the International Bureau for Epilepsy, Understanding the real-life effects of epilepsy in children: 'Future in Mind' - an international survey of parents, healthcare professionals and children Presented at the 27th International Epilepsy Congress, 8 - 12 July 2007, Singapore

[ii] World Health Organisation. Epilepsy Facts. Available here [Last accessed May 2007]
 
 
Google
Web www.iconocast.com

Search inside Iconocast for the keyword you have in mind.

Iconocast has collected more than 50,000 articles and press releases on health and science.

These are current and most up to date press releases on the subject you are searching.

We collect current health and science press releases daily from more than 5000 research and health institutes. Here is an example : The elderberry way to perfect skin

We believe if you do search inside Iconocast, you will get better results than searching the web alone.

 
 
Continue News With: News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

Contact Iconocast

© 2003-07. ICONOCAST is a trademark of iconocast.com.